Comorbidities: glucocorticoids and osteoporosis: predicting fracture risk.

摘要

This month the American College of Rheumatology (ACR) publishes its 2010 "Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis (GIOP)". The previous recommendations were published in 2001 and the knowledge base regarding fracture risk with glucocorticoid exposure has been better defined over the past decade. Additionally, randomized clinical trials of new therapies for GIOP, such as zoledronate and teri-paratide, have been published since that time.4'5 The leadership of the ACR therefore felt that an update was necessary and, after a request for proposals, awarded a grant to Grossman and colleagues to develop the new recommendations.